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OBJECTIVE: Postsurgical abdominal adhesions are common, serious postoperative complications. The present study
compared the usefulness of 4% icodextrin and canola oil in preventing postoperative peritoneal adhesions.
METHODS: Twenty-four Wistar albino rats were divided into three groups. Following a laparotomy, a serosal
abrasion was made by brushing the cecum, and 3 mL of 0.9% NaCl, 4% icodextrin, or 3 mL of canola oil were
intraperitoneally administered for the control, icodextrin, and canola oil groups, respectively. The abdomen was
then closed. All of the rats were sacrificed at day 10. Macroscopic, histopathological, and biochemical evaluations
were performed. The results were statistically analyzed using Kruskal–Wallis and ANOVA tests.
RESULTS: Macroscopic analyses revealed that both canola oil and 4% icodextrin reduced adhesion formation, but
the difference was not statistically significant (p= 0.17). The histopathological examinations revealed no significant
differences in terms of giant cell, lymphocyte/plasmocyte, neutrophil, ICAM1, or PECAM1 scores. However, both
canola oil and 4% icodextrin significantly reduced fibrosis (p= 0.025). In the canola oil group, the histiocytic
reactions were significantly increased (p= 0.001), and the hydroxyproline levels were significantly lower than those
in the other groups (p= 0.034).
CONCLUSIONS: In the present study, canola oil was determined to be superior to 4% icodextrin in lowering
hydroxyproline levels and increasing histiocytic reactions. Considering these results, we believe that canola oil is a
promising agent for preventing adhesion formation.
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INTRODUCTION
Postoperative peritoneal adhesions are major complica-
tions in abdominopelvic surgery, occurring in 60-93% of
patients (1,2). These adhesions can result in major post-
operative complications, such as intestinal obstruction,
infertility, and chronic pelvic pain and can require re-
admission and further operations (1-3). In addition to
medical problems, increased surgical costs are an additional
concern. An American study reported a total cost of $1.3
billion annually for the treatment of postoperative perito-
neal adhesions (4).
Peritoneal adhesions that occur following surgical trauma
are caused by metabolic processes and the combination of a
large number of inflammatory and anti-inflammatory pro-
cesses. Peritoneal adhesions are initiated by tissue damage
and can cause a coagulation cascade over the course of
several hours. Following coagulation, the inflammation
phase begins within the first few postoperative days. Cell
seeding, proliferation, migration and matrix deposition occur
in the first week postoperatively. Lastly, the matrix remodel-
ing phase lasts over a period of weeks to months (5).
Several studies have aimed to reduce the frequency of this
commonly encountered condition. Progesterone, soybean
oil, aloe vera gel, vitamin E, methylene blue, and amniotic
membrane have been frequently used in experimental
studies of peritoneal adhesion prevention (5-12). These
materials are most commonly instilled and/or lavaged into
or around the peritoneal cavity in a liquid, gel or spray
form. Some of these substances have been used to inhibit
adhesion formation (i.e., coagulation, inflammation and
matrix formation), and others separate the peritoneal
surfaces.
A corn starch derivative, icodextrin is a water-soluble
branched glucose polymer; its monomers are linked by
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alpha (1-4) and alpha (1-6 [,10%]) glucosidal bonds. When
administered intraperitoneally in a 4% solution, icodextrin
functions as a colloidal osmotic agent. The colloidal osmotic
action of this polymer retains a reservoir of fluid within
the peritoneal cavity for 3-4 days. Icodextrin provides a
temporary physical separation of the peritoneal surfaces by
hydroflotation as the result of maintaining a fluid reservoir.
This effect minimizes tissue apposition during the critical
period of fibrin formation and mesothelial regeneration
following surgery, thereby providing a barrier to adhesion
formation (13).
Canola oil, which is also referred to as low erucic acid
rapeseed oil, is a vegetable oil that contains monounsaturated
fatty acids, oleic acid (55%), and polyunsaturated fatty acids
(PUFAs), which are composed of linoleic acid (v-6) (25%) and
alpha-linoleic acid (v-3) (10%). Canola oil has the lowest
concentration of saturated fatty acids (SFA, 4%) of all the
commonly consumed oils, and it is a good source of vitamins
E and K and phytosterols (14). Although erucic acid is a
monounsaturated fatty acid and a member of the v-9 FA
family, it metabolizes to oleic acid and has anti-inflammatory
effects (15). V-3 PUFAs are essential nutrients that play a
beneficial role in several disease processes because of their
anti-inflammatory, analgesic, anti-thrombotic, and anti-
mutagenic effects. These fatty acids also modulate some
forms of lipids and positively affect the central nervous
system. In contrast, v-6 fatty acids have inflammatory,
nociceptive, thrombotic, and mutagenic effects.
Canola oil is a lipid that can separate the traumatic
peritoneal surfaces, and it contains fatty acids that can
inhibit adhesion formation; therefore, it may successfully
prevent peritoneal adhesions. Thus, the aim of this experi-
mental study is to compare the macroscopic, histopatholo-
gical and biochemical effects of icodextrin and canola oil in
preventing postoperative peritoneal adhesions.
MATERIALS AND METHODS
This study was performed at the Experimental Animal
Laboratory of Marmara University Medical Faculty after
obtaining approval from the Animal Ethics Committee. All
of the protocols followed the declaration of Helsinki
guidelines concerning the care and use of laboratory
animals.
Twenty-four Wistar albino outbred female rats (mean
weight 250¡30 g, mean age seven months) were divided
into three groups and were housed in standard rat cages,
each containing a maximum of five rats. The rats were
housed using a 12-hr light/12-hr dark cycle at stable
temperatures (between 19 and 22 C˚). The animals were
provided with standard rat pellet and tap water ad libitum.
Operation and adhesion model
Following a 12-hour starvation, the rats were anaesthe-
tized with IM ketamine hydrochloride (KetalarTM,
Eczacıbas¸ı, Istanbul-Turkey) at 40 mg/kg and xylazine
(ROMPUNTM, Bayer, Berlin Germany) at 10 mg/kg body
weight. The rats were placed in a supine position, and their
extremities were affixed to the operating table with plaster.
All of the operations were performed using powder-free,
non-latex gloves to prevent the anticipated peritoneal
adhesions caused by foreign body reactions. After abdom-
inal skin shaving, antisepsis was maintained using povi-
done iodine (BetadineTM, Kurtsan, Istanbul-Turkey).
A laparotomy was performed via a 3 cm midline incision.
The cecum was pulled from the abdomen and scrubbed five
times with a sterile toothbrush to induce a subserosal
hemorrhage on an area that was equivalent to the tooth-
brush surface. The cecum was then returned to its normal
position.
Prior to closing the abdomen, 3 mL of 0.9% saline solution
(Eczacibasi-Baxter, Istanbul-Turkey), 3 mL of 4% icodextrin
(ADEPTTM, Baxter, Deerfield, USA), or 3 mL of canola oil
(YudumTM Canola Oil, Balikesir-Turkey), which was ster-
ilized in an autoclave and cultured prior to use, were
intraperitoneally administered to the three groups of rats
(n = 8 each).
To overcome fluid leakage from the peritoneal cavity, the
wound edges were held together by four clamps immediately
following the application of the protocol material. The
abdominal incision was subsequently closed with 4-0 poly-
propylene running sutures (ProleneTM, Ethicon, Cornelia, GA,
USA). Then, 100 mL/kg of paracetamol (PerfalganTM, Bristol
Myers Squibb, Park Avenue, NY, USA) was injected
subcutaneously for analgesia. Normal feeding was allowed
after 6 hours. Wound healing and abdominal wall integrity
were assessed daily over the first three days following the
surgery. All of the rats were sacrificed 10 days postoperatively
using a high dose (100-150 mg/kg) of sodium thiopental
(PentotalTM, Abott, Illinois, USA).
Macroscopic assessment
The peritoneal cavity was entered via a ‘‘reverse U’’
incision without damaging the formed adhesions. Retracting
the anterior abdominal wall caudally, the peritoneal cavity,
the small bowels and the cecumwere carefully inspected and
assessed according to the Blauer staging scale (16) (Table 1).
Following a macroscopic evaluation, a 2-cm ileocecal
segment and its neighboring mesenteric root (0.560.5 cm)
were resected for the histopathological and biochemical
examinations. The sacrificed animals were placed in the
Marmara University Experimental Animal Laboratory’s
medical waste, and the study was completed.
Histopathological assessment
The resected adhesion model specimen was fixed in a
10% formalin solution. Following dehydration, the samples
were paraffin-embedded using tissue processing equipment
(Leica ASP300S, Newcastle-UK). Four 3 mm-thick slices from
each intestinal segment were obtained using a microtome
(Leica RM2255, Newcastle-UK).
As defined by the producers of the standard protocol, the
first section was stained with hematoxylin and eosin (HE)
(Bio optica, Milano-Italy, Bio stain, Manchester-UK) to
assess giant cell, lymphocyte/plasmocyte, neutrophil, and
histiocyte reactions. The second section was stained with
Masson Trichrome (Sigma Aldrich, St. Louis, MO-ABD) to
assess fibrosis. The third section was stained for CD54/
ICAM1 (NovocastraTM Leica, Newcastle-UK, 23G12 clone)
and CD31/PECAM1 (NovocastraTM Leica, Newcastle-UK,
1A10 clone).
The slides that were stained with HE to assess the giant
cell, lymphocyte/plasmocyte, neutrophil, and histiocyte
reactions, as well as the slides that were stained with
Masson Trichrome for the fibrosis analysis, were scored
from zero to three based on the criteria that were used by
Delaco et al. (17). The two slides that were stained for CD54
and CD31 were also stratified from zero to three, as shown
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in Table 1. The microscopic assessment was made using
light microscopy (Nikon E600, Tokyo-Japan) under 100x
and 200x magnifications. Images were obtained of the
observed samples (Nikon E5400, Tokyo-Japan). The pathol-
ogist was blinded to the study group.
Biochemical assessment
The mesenteric tissue samples that were used for the
biochemical assessment were kept in dry tubes and taken to
the biochemistry laboratory. After collecting all of the
tissues, 70 mg of tissue were homogenized in a 1 mL 0.9%
NaCl solution (Janke & Kunkel Ultra-Turrax T25, Staufen-
Germany). After adding equal volumes of HCl, the
homogenized tissues were incubated for 24 hours in a
95 C˚ water bath.
The compounds that were used for the analysis, i.e.,
acetate citrate buffer (pH 6.5), chloramine T and Erlich
reactive, were all purchased from Sigma Aldrich St. Louis,
MO, USA, and were freshly prepared. A standard hydro-
xyproline study was prepared. After completing the study,
the absorbency values from the samples and the standards
were quantified using a spectrophotometer (Beckman
Coulter DU-530, Brea, CA, USA).
Statistical analyses
All of the statistical analyses were performed using the
SPSS statistical software package (version 16.0, IBM, USA).
The numerical data were expressed as the mean and
standard derivation, unless otherwise stated. Because the
values were nonparametric and the number of rats in the
groups was under 30, the Kruskal–Wallis test was used for
the statistical analysis of the giant cell, lymphocyte/plasmo-
cyte, neutrophil, and histiocyte reactions and for the fibrosis,
ICAM1 and PECAM1 scores. The statistical significance of
the hydroxyproline levels was assessed using an ANOVA
test given that all of the values that were obtained from the
three groups were parametric. The results were evaluated
with a confidence interval of 95%, and p-values below 0.05
were considered to be statistically significant.
RESULTS
No postoperative complications, such as bowel obstruc-
tions and peritonitis, or mortality was observed in any of the
groups during the study. At necropsy assessment, no
intraperitoneal fluid was found at day 10.
Macroscopic assessment
The rats in both the canola and the icodextrin groups,
nearly half of which were free from adhesions, appeared to
have lower macroscopic scores than those in the control
group. However, this difference was not statistically
significant (p= 0.17) (Table 2, Figure 1).
Histopathological assessment
The microscopic assessment of the giant cell (p= 0.381),
lymphocyte/plasmocyte (p= 0.126), and neutrophil reac-
tions (p= 0.307) revealed no statistically significant differ-
ence in comparison between the control, icodextrin and
canola groups.
Although no histiocytic reaction was observed in the
sham or the icodextrin-treated groups, a significant histio-
cytic reaction was observed in the rats in the canola oil-
treated group: two rats had scores of zero; three rats had
scores of one; and three rats had scores of two (p= 0.001)
(Table 2, Figure 1).
The fibrosis assessment revealed that both the icodextrin-
and the canola oil-treated groups exhibited significantly
decreased fibrotic reactions compared to the control group;
none of the icodextrin- or canola-treated rats received a
score of three (p= 0.025) (Table 2, Figure 1).
The immunohistochemistry studies revealed that the rats
in the control and icodextrin groups expressed higher ICAM
and PECAM1 levels in the cellular membranes: the mean
Table 1 - The scoring system used for the macroscopic and microscopic evaluations of the inflammatory reactions on
serosal surfaces (16).
SCORE Macroscopic findings Cellular reaction* Fibrosis ICAM1 and PECAM1 staining
0 No adhesions None None None
1 Thin and narrow, easily separable
adhesions
Rare Rare ,10%
2 Thick adhesions, limited to one area Mild Mild 10-50 %
3 Thick and wide adhesions Severe Severe .50%
4 Thick and wide adhesions between the
organs and the abdominal wall
NA** NA** NA**
*: Giant cell, lymphocyte/plasmocyte, neutrophil, and histiocyte reactions. **NA: not available.
Table 2 - The mean scores that were obtained from the gross evaluation and the histopathological and biochemical
assessments of each study group.
Scores Control Icodextrin Canola p-value
Macroscopic assessment 1.75¡1.04 1.12¡1.13 0.75¡1.06 0.17
Giant cell 1.00¡0.76 0.75¡0.89 1.38¡0.92 0.381
Lymphocyte / plasmocyte 1.12¡0.35 1.50¡0.76 1.00¡0.00 0.126
Neutrophil 1.12¡0.84 1.00¡1.11 0.50¡0.54 0.307
Histiocyte 0.00¡0.00 0.00¡0.00 1.12¡0.84 0.001
Fibrosis 1.88¡0.64 1.00¡0.76 1.00¡0.54 0.025
ICAM1 1.25¡0.70 1.75¡1.04 0.88¡0.64 0.14
PECAM1 1.12¡0.83 1.38¡0.74 0.50¡0.54 0.069
Hydroxyproline 302.65¡147.69 273.40¡118.56 151.14 ¡53.30 0.034
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ICAM scores were 1.25¡0.70, 1.75¡1.04 and 0.88¡0.64 for
the control, icodextrin-treated and canola oil-treated groups,
respectively; the mean PECAM1 scores were 1.12¡0.83,
1.38¡0.74 and 0.54¡0.50 for the control, icodextrin-treated
and canola oil-treated groups, respectively. However, there
was no statistically significant difference between the three
groups (p= 0.14 and p= 0.069) (Table 2, Figure 1).
Biochemical assessment
The mean hydroxyproline levels were 302.65¡
147.69, 273.40¡118.56 and 151.14¡53.30 in the control,
icodextrin-treated, and canola oil-treated groups, respec-
tively. The statistical analysis revealed a significant decrease
in hydroxyproline levels in the canola oil-treated group
(p=0.034) (Table 2).
DISCUSSION
Postoperative peritoneal adhesions can lead to read-
missions and reoperations caused by mechanical small
bowel obstruction, which can increase clinical workloads
and hospital costs. Many preventive measures have been
Figure 1 - The results of the macroscopic and histopathological assessments of the study groups.
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proposed to overcome this problem, including meticulous
surgical techniques, excellent intraoperative hemostasis,
avoiding unnecessary handling of the bowel, creating
devitalized or ischemic tissue, minimizing the risk of foreign
body granulomas (primarily surgical glove powder and
excessive suture material), and preventing peritoneal con-
tamination; even certain serosal plication techniques have
been proposed to overcome this problem (18).
In addition to these techniques, a wide range of
biologically active substances in the form of simple fluids,
gels and solids, either combined or alone, have been
investigated both clinically and experimentally to reduce
or prevent abdominal adhesions (19). These novel
approaches aim to prevent adhesion formation by physi-
cally separating the surgically manipulated areas via
irrigation and instillation or by covering the serosal surfaces
with liquid agents or barriers in the form of films, sprays or
gels. Carboxymethyl cellulose + hyaluronic acid is the most
examined material (20-26).
Oxidized regenerated cellulose and polytetrafluoroethy-
lene are two other synthetic absorbable barriers that have
been shown to effectively reduce the incidence of surgical
adhesions (27).
An ideal barrier should be biodegradable, biocompatible
and surgically easy to handle and should act locally to avoid
side effects. However, only certain materials meet all of
these requirements, and no large prospective, randomized
double-blind human studies have demonstrated their
efficacy. Furthermore, none of these materials have been
widely adopted by surgeons, indicating that the materials
only decrease adhesion severity, not incidence (28,29).
The effect of a 4% icodextrin solution, which has received
limited approval by the FDA for use in laparoscopic
gynecological surgery, was largely investigated using
ARIEL registry data. These results indicated that this
solution was widely accepted by both gynecological
surgeons and patients (30). This clinical evaluation had
been conducted in patients who underwent a routine
gynecological surgery via either laparoscopy or laparotomy
in six European countries. The participating surgeons were
asked to use 4% icodextrin solutions for the lavage and
instillation of the peritoneal cavity. A questionnaire was
used to assess the patients’ experiences, and it revealed a
high acceptability rate of this method, with low rates of
adverse events (7.5% and 13.9% of the patients who
underwent laparoscopy and laparotomy, respectively) (31).
The same group achieved similar results in general surgery
patients but observed a substantial number of adverse
effects (16.7% and 30.6% of the patients who underwent
laparoscopy and laparotomy, respectively) (32). Never-
theless, in the context of laparoscopic pelvic surgery, the
use of this solution is avoided in bowel resections and
peritoneal inflammatory conditions, which may require
more robust adhesion prevention techniques.
It is believed that other agents and pharmaceutics in the
form of gels, sprays or liquids might be rapidly absorbed by
the peritoneum. Studies of these compounds, which were
performed primarily in animals, demonstrated conflicting
results (5-12,17). Thus, more evidence is needed.
The mechanism of peritoneal healing is similar to wound
healing. However, regardless of the size of the peritoneal
trauma, healing requires approximately 7-10 days. Peritoneal
leukocytes, histiocytes, and tissue-consolidating mature
macrophages are components of the monocyte-phagocytic
system. These cell types are the most important chronic
inflammation-mediating cells with respect to the subsequent
response of other immune cells and the cellular mediators to
injury. A fibrin matrix is exuded from inflammatory cells,
and this matrix is gradually organized into fibrin bands that
contain fibroblasts, macrophages and giant cells that bridge
the two injured peritoneal surfaces (33). Several animal
studies have revealed the cellular response to peritoneal
damage, and many therapeutics have been designed to
prevent adhesion formation by interacting with the extra-
cellular matrix and cellular mediators. Thus, it appears that
the complex relationship between peritoneal healing and
adhesion formation will continue to be investigated until the
pathogenesis of adhesions is completely understood.
In certain studies, polyunsaturated fatty acids and their
derivatives, eicosapentaenoic acid and docosahexaenoic
acid, have been observed to promote peritoneal wound
healing by activating the inflammatory cascade via peroxi-
some proliferator activated receptors (PPARs). This activa-
tion, which mediates lipid metabolism, fatty acid oxidation,
and cytokine production, can induce the anti-adhesogenic
effects of v-3 fatty acids. This effect is mediated by reducing
the levels of type 1 collagen, vascular endothelial growth
factor, and transforming growth factor b-1 (34). This
tremendous modulation of the inflammatory response
indicates the potential anti-adhesive effects of PUFAs.
However, whether this action is beneficial or detrimental
in clinical wound healing is unknown.
PUFAs affect numerous physiological processes that
modulate the physical properties of the lipid bilayer
composition and the fluidity of the cell membrane. Our
study focused on the cellular response to peritoneal damage
and revealed a significant decrease in fibrosis in the canola
oil-treated group compared to the icodextrin-treated and
control groups. Although both icodextrin and canola oil
reduced adhesions macroscopically, this alteration did not
reach statistical significance. Meanwhile, cellular reactions,
such as giant cells, mononuclear and polymorph nuclear
leukocyte reactions, did not differ in any of the groups. This
result may be explained as the neutral effect of both of the
tested anti-adhesion materials on normal wound healing. In
contrast, a very prominent histiocytic reaction was observed
in the canola oil-treated group (1.12¡0.84), whereas no such
reaction was observed in the other two groups. This result
suggests that tissue macrophages also contributed to the
inflammatory process in animals following canola oil
treatment.
Soybean oil, which contains linoleic acid (51%), oleic acid
(25%), methyl methacrylate, palmitic acid, linolenic acid,
and stearic acid, have been experimentally tested for their
abilities to decrease the severity of postoperative peritoneal
adhesions and have been reported to decrease adhesion
formation when applied prior to the peritoneal trauma (6).
Vitamin E, when applied just prior to the closing of the
incision, was effective in reducing adhesion formation (8). In
agreement with this previous study, Durmus et al. demon-
strated that vitamin E and selenium, which are believed to
be commonly used antioxidants, thoroughly decreased
fibrosis and intra-abdominal adhesions by reducing hydro-
gen peroxides and lipid hydroperoxides to nontoxic
elements (35). Canola oil, a good source of vitamin E, may
also prevent peritoneal adhesions.
The fact that no dose adjustments were performed in the
canola oil-treated group is an important limitation of the
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present study. The effect of intraperitoneally administering
canola oil has, to our knowledge, never been examined.
Further investigations are required to determine the most
effective dose and form in which canola oil can optimally
prevent adhesions.
Given the benefits of canola oil in inducing the histiocytic
reaction and lowering hydroxyproline levels, the data that
are presented here demonstrate that intraperitoneally
administered canola oil decreases collagen synthesis and
has no detrimental effect on the wound healing process.
Compared with icodextrin, canola oil may be a promising
agent in the prophylaxis of adhesion formation.
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